Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-04
2011-01-04
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S764000
Reexamination Certificate
active
07863287
ABSTRACT:
The present invention is directed to a pharmaceutical composition and method for the treatment of rhinitis and cold-like symptoms which includes a non-steroidal anti-inflammatory drug (NSAID), a decongestant, and an antihistamine. It has been found that an NSAID enhances the activity of a decongestant and an anti-histamine, thus permitting a reduction in either or both in administration of separate dosage forms. The same enhancement can also occur with an anti-tussitive. Thus, the effective amount of the decongestant or the antihistamine or both is less than about 75% of an amount present in an approved dose of the decongestant or the antihistamine, or both, relative to an amount of the NSAID corresponding to about 100% of the amount present in a normal strength dosage form of the NSAID.
REFERENCES:
patent: 4522826 (1985-06-01), Sunshine et al.
patent: 4552899 (1985-11-01), Sunshine et al.
patent: 4585783 (1986-04-01), Sunshine et al.
patent: 4683243 (1987-07-01), Sunshine et al.
patent: 4738966 (1988-04-01), Sunshine et al.
patent: 4749697 (1988-06-01), Sunshine et al.
patent: 4749711 (1988-06-01), Sunshine et al.
patent: 4749720 (1988-06-01), Sunshine et al.
patent: 4749721 (1988-06-01), Sunshine et al.
patent: 4749722 (1988-06-01), Sunshine et al.
patent: 4749723 (1988-06-01), Sunshine et al.
patent: 4755532 (1988-07-01), Sunshine et al.
patent: 4783465 (1988-11-01), Sunshine et al.
patent: 4829064 (1989-05-01), Sunshine et al.
patent: 4839354 (1989-06-01), Sunshine et al.
patent: 4840962 (1989-06-01), Sunshine et al.
patent: 4871733 (1989-10-01), Sunshine et al.
patent: 4906625 (1990-03-01), Sunshine et al.
patent: 4920149 (1990-04-01), Sunshine et al.
patent: 4952402 (1990-08-01), Sparks et al.
patent: 4975426 (1990-12-01), Sunshine et al.
patent: 4985459 (1991-01-01), Sunshine et al.
patent: 4990535 (1991-02-01), Cho et al.
patent: 5025019 (1991-06-01), Sunshine et al.
patent: 5133974 (1992-07-01), Paradissis et al.
patent: 5196436 (1993-03-01), Smith
patent: 5288479 (1994-02-01), Gorman et al.
patent: 5374659 (1994-12-01), Gowan, Jr.
patent: 5466865 (1995-11-01), Geyer et al.
patent: 5492689 (1996-02-01), Gwaltney
patent: 5560913 (1996-10-01), Kupper
patent: 5622723 (1997-04-01), Bettman et al.
patent: 5681577 (1997-10-01), Lech et al.
patent: 5869479 (1999-02-01), Kreutner
patent: 5895663 (1999-04-01), Irwin et al.
patent: 6090411 (2000-07-01), Pillay et al.
patent: 6210710 (2001-04-01), Skinner
patent: 6270796 (2001-08-01), Weinstein
patent: 6294195 (2001-09-01), Oshlack et al.
patent: 6337091 (2002-01-01), Kim et al.
patent: 6384054 (2002-05-01), Woosley
patent: 6517868 (2003-02-01), Fassihi et al.
patent: 6709676 (2004-03-01), Cho
patent: 738274 (2001-09-01), None
patent: 2084028 (1993-05-01), None
patent: 0674517 (1995-10-01), None
patent: 2002316927 (2002-10-01), None
patent: 85/04589 (1985-10-01), None
patent: 0448895 (1991-10-01), None
patent: 92/04021 (1992-03-01), None
patent: 92/04022 (1992-03-01), None
patent: 92/17171 (1992-10-01), None
patent: 94/14449 (1994-07-01), None
patent: 94/14476 (1994-07-01), None
patent: 95/07079 (1995-03-01), None
patent: 95/07103 (1995-03-01), None
patent: 95/11677 (1995-05-01), None
patent: 97/04808 (1997-02-01), None
patent: 97/04808 (1997-03-01), None
patent: 98/06436 (1998-02-01), None
patent: 99/15173 (1999-04-01), None
patent: 01/21168 (2001-03-01), None
patent: 03/089007 (2003-10-01), None
patent: 2005/063219 (2005-07-01), None
patent: 02/96406 (2005-12-01), None
Winter, et al.,The Therapeutic Effectiveness of Ibuprofen on the Symptoms of Naturally Acquired Acquired Common Colds, American Journal of Rhinology, 15 (2001), 239-242.
Sperber, et al.,Evaluation of an Alpha Agonist Alone and in Combination with a Nonsteroidal Antiinflammatory Agent in the Treatment of Experimental Rhinovirus Colds, Bull. N.Y. Acad. Med., 65 (1989), 145-160.
Chua et al: “Cardiovascular effects of a chlorpheniramine/paracetamol combination in hypertensive patients who were sensitive to the pressor effect of pseudoephedrine” Br J Clin Pharmacol. Mar. 1991; 31(3):360-2.
Sperber et al: “Evaluation of an alpha antagonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds” BII NY Acad. Med. Jan. 1989 65(1): 145-60.
Weidinger et al.: “Oral phenylephrine: An ineffective replacement for pseudoephedrine?” The Journal of Allergy and Clinical Immunology. 2006. vol. 118 No. 1. pp. 279-280.
Children's Dimetapp® product information (http://www.dimetapp.com/coldlbl,—chew.asp).
Sudafed PE® product information (http://www.sudafed.com/products/sudafed—pe.html).
Children's Sudafed® product information (http://www.sudafed.com/products/childrens—chewables.htm).
Sudafed® product information ( http://www.sudafed.com/products/sudafed.html).
Claytor Renee
Gold Jeffrey M.
Padmanabhan Sreeni
Wyeth LLC
LandOfFree
Compositions of non-steroidal anti-inflammatory drugs,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions of non-steroidal anti-inflammatory drugs,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of non-steroidal anti-inflammatory drugs,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2707876